News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
91,010 Results
Type
Article (3831)
Company Profile (9)
Press Release (87167)
Section
Business (35298)
Career Advice (92)
Deals (5517)
Drug Delivery (11)
Drug Development (10734)
Employer Resources (6)
FDA (1952)
Job Trends (2273)
News (48991)
Policy (3642)
Tag
2027 Biotech Beach Elite (1)
2027 Genetown Standard (1)
Academia (247)
Accelerated approval (16)
ADA (6)
Adcomms (1)
Allergies (39)
Alliances (3245)
ALS (22)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (112)
Approvals (2160)
Artificial intelligence (84)
ASCO (78)
Autoimmune disease (79)
Automation (12)
Bankruptcy (36)
Belgium (3)
Best Places to Work (2029)
BIO (4)
Biologics (3)
BIOSECURE Act (2)
Biosimilars (40)
BioSpace Insights (9)
Biotechnology (8)
Bladder cancer (77)
Brain cancer (14)
Breast cancer (199)
Cancer (1340)
Cardiovascular disease (107)
Career advice (83)
Career pathing (2)
CAR-T (44)
CDC (6)
CDMO (40)
Cell therapy (125)
Cervical cancer (12)
Clinical research (10699)
Collaboration (210)
Commercialization (3)
Company closure (1)
Compensation (141)
Complete response letters (10)
COVID-19 (286)
CRISPR (13)
C-suite (95)
Cystic fibrosis (16)
Data (2127)
Denatured (1)
Depression (34)
Dermatology (48)
Diabetes (142)
Diagnostics (943)
Digital health (9)
Diversity (1)
Drug discovery (43)
Drug pricing (20)
Drug shortages (2)
Duchenne muscular dystrophy (70)
Earnings (28855)
Editorial (7)
Employer branding (1)
Employer resources (4)
Events (13963)
Executive appointments (73)
Eye disease (1)
FDA (2872)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (188)
Gene editing (33)
Generative AI (5)
Gene therapy (101)
GLP-1 (244)
Government (548)
Grass and pollen (2)
Guidances (263)
Healthcare (2735)
Hematology (47)
HIV (34)
Huntington's disease (18)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (28)
Immunology and inflammation (59)
Immuno-oncology (24)
Indications (65)
Infectious disease (346)
Inflammatory bowel disease (36)
Inflation Reduction Act (2)
Influenza (26)
Intellectual property (39)
Interviews (10)
IPO (3828)
IRA (5)
Job creations (328)
Job search strategy (72)
JPM (37)
Kidney cancer (9)
Kidney disease (19)
Labor market (32)
Layoffs (71)
Leadership (5)
Legal (695)
Licensing (9)
Liver cancer (22)
Longevity (4)
Lung cancer (211)
Lung diease (1)
Lymphoma (123)
Machine learning (9)
Management (2)
Manufacturing (134)
Marketing (4)
MASH (69)
Medical device (2099)
Medtech (2153)
Mergers & acquisitions (1912)
Metabolic disorders (372)
mRNA (56)
Multiple sclerosis (54)
NASH (3)
Netherlands (4)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (606)
Neurotech (1)
NextGen: Class of 2026 (708)
Non-profit (502)
Now hiring (6)
Obesity (155)
Opinion (27)
Ovarian cancer (42)
Pain (29)
Pancreatic cancer (70)
Parkinson's disease (53)
Partnered (2)
Patents (79)
Patient recruitment (88)
Patient selection (3)
Peanut (18)
People (3469)
Peptides (2)
Pharmaceutical (1)
Pharmacy benefit managers (3)
Phase 1 (2388)
Phase 2 (4336)
Phase 3 (4663)
Pipeline (3582)
Policy (28)
Postmarket research (443)
Preclinical (825)
Press Release (6)
Prostate cancer (69)
Psychedelics (13)
Radiopharmaceuticals (58)
Rare diseases (206)
Real estate (398)
Recruiting (3)
Regenerative medicine (2)
Regulatory (3418)
Reports (21)
Research institute (191)
Resumes & cover letters (14)
Rett syndrome (13)
RNA editing (6)
RSV (17)
Schizophrenia (63)
Series A (26)
Series B (19)
Service/supplier (1)
Sickle cell disease (18)
Special edition (11)
Spinal muscular atrophy (36)
Sponsored (5)
Startups (218)
Stomach cancer (3)
Substance use disorders (7)
Supply chain (13)
Tariffs (11)
The Weekly (5)
Vaccines (157)
Venture capital (24)
Weight loss (117)
Wet AMD (1)
Women's health (21)
Worklife (1)
Date
Today (6)
Last 7 days (126)
Last 30 days (378)
Last 365 days (6229)
2026 (4846)
2025 (5222)
2024 (5928)
2023 (6608)
2022 (7175)
2021 (7584)
2020 (6800)
2019 (5991)
2018 (4432)
2017 (3910)
2016 (3404)
2015 (4291)
2014 (3088)
2013 (2212)
2012 (2525)
2011 (2602)
2010 (2398)
Location
Africa (74)
Alabama (16)
Arizona (35)
Arkansas (2)
Asia (5635)
Australia (688)
California (2828)
Canada (755)
China (278)
Colorado (149)
Connecticut (103)
Delaware (145)
Europe (13866)
Florida (397)
Georgia (82)
Hawaii (2)
Idaho (3)
Illinois (211)
India (26)
Indiana (174)
Iowa (3)
Japan (165)
Kansas (20)
Kentucky (12)
Louisiana (21)
Maine (23)
Maryland (287)
Massachusetts (1773)
Michigan (78)
Minnesota (163)
Mississippi (2)
Missouri (18)
Montana (7)
Nebraska (4)
Nevada (30)
New Hampshire (11)
New Jersey (1003)
New Mexico (3)
New York (797)
North Carolina (364)
Northern California (1556)
Ohio (64)
Oklahoma (2)
Oregon (2)
Pennsylvania (552)
Puerto Rico (2)
Rhode Island (2)
South America (155)
South Carolina (6)
Southern California (1065)
Tennessee (41)
Texas (398)
United States (9790)
Utah (71)
Virginia (48)
Washington D.C. (6)
Washington State (207)
West Virginia (1)
Wisconsin (23)
91,010 Results for "26".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immuron Reports FY26 Preliminary Results
August 28, 2026
·
11 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Press Releases
Propanc Biopharma Provides Corporate Update & Year-End June 30, 2025-26, Financial Results
September 29, 2026
·
13 min read
China
Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
Investors looking for more transformative business development at Novo will have to wait, but a new partnership with China’s Hengrui Pharma adds a new weekly oral option to the Danish pharma’s early pipeline.
September 29, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 26 August 2026
August 20, 2026
·
1 min read
Press Releases
Coloplast A/S - Interim Financial Report, 9M 2025/26
August 18, 2026
·
5 min read
Press Releases
Immutep Quarterly Activities Report Q4 FY26
July 30, 2026
·
12 min read
Press Releases
RenX Enterprises Announces $2.6 Million Sale Agreement for Norman Berry Property
August 23, 2026
·
6 min read
Press Releases
Medincell Reports FY 2025-26 Annual Results
June 17, 2026
·
2 min read
Press Releases
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
August 28, 2026
·
10 min read
1 of 9,101
Next
